Department of Surgery »  Faculty »  General Surgery »  Quan-Yang Duh, M.D.

Quan-Yang Duh, M.D.

Professor of Surgery
Division of General Surgery
Chief, Section of Endocrine Surgery

Contact Information

Endocrine Surgical and Oncology Clinic
1600 Divisadero St., Third Floor
San Francisco, CA 94115
Phone: (415) 353-7687
Fax: (415) 353-7781
quan-yang.duh@ucsf.edu
VAMC Surgical Services
Voice:(415) 750-2131
FAX: (415) 514-1133
Open Popup
  • 1973-77, Yale University, New Haven, CT, B.S., Molecular Biophysics & Biochemistry
  • 1977-81, University of California, San Francisco, M.D., Medicine
  • 1981-82, University of California, San Francisco, Intern, General Surgery
  • 1982-88, University of California, San Francisco, Resident, General Surgery
  • 1981-82, University of California, San Francisco, Postdoctoral Fellow, Surgery, General
  • 1982-88, University of California, San Francisco, Postdoctoral Fellow, Surgery, General  
  • American Board of Surgery, 1989
  • Endocrine Surgical Oncology Program
  • UCSF Comprehensive Cancer Center
  • Associate-Director, Videoscopic Training Program

Dr. Quan-Yang Duh is Professor and Chief of Endocrine Surgery and Associate Director of Advanced Videoscopic Surgery Center at UCSF. He is an attending Surgeon at both UCSF Medical Center and San Francisco VA Medical Center. He is also fluent in Mandarin and Taiwanese.

Dr. Duh specializes in surgery to treat tumors of the thyroid, parathyroid and adrenal glands, as well as endocrine and gastrointestinal malignancies. He is nationally and internationally recognized  for his expertise in complex minimally invasive procedures including laparoscopic adrenalectomy, thyroidectomy, parathyroidectomy and hernia repair.

Dr. Duh graduated from Yale University, New Haven, CT with a B.S. in Molecular Biophysics and Biochemistry. He completed his surgical internship, residency and postdoctoral fellowship at the University of California, in San Francisco. He is the past president of the American Association of Endocrine Surgeons and the San Francisco Surgical Society, as well as president of the American College of Surgeons' Northern California Chapter. Highly respected by his peers, Dr. Duh was named to the list of U.S. News "America's Top Doctors," a distinction reserved for the top 1% of physicians in the nation for a given specialty.

Dr. Duh's research in endocrine cancer involved oncogenesis, genetic alteration and redifferentiation treatment of thyroid cancer and adrenal tumors.  His clinical research involved patients with adrenal diseases (aldosteronoma, pheochromocytoma, Cushing, incidentaloma and adrenal metastasis), and minimally invasive parathyroid and thyroid operations.

Dr. Duh has developed and actively teaches several new techniques for advance laparoscopic surgery. He has authored or co-authored more than 250 articles and textbook chapters on topics of endocrine surgery and laparoscopic surgery. Dr. Duh was the Site Principal Investigator for a multi-center Veterans Affairs Medical Center prospective randomized trail of open mesh versus laparoscopic inguinal hernia repair, the results of which was published in New England Journal of Medicine. He has started the program in robot-assisted laparoscopic general surgery at the VA Medical Center, currently focused on inguinal hernias.

Most recent publications from a total of 322
  1. Balkin DM, Duh QY, Kind GM, Chang DS, McGrath MH. Failed pneumoperitoneum for laparoscopic surgery following autologous Deep Inferior Epigastric Perforator (DIEP) flap breast reconstruction: a case report. BMC Surg. 2016; 16(1):28. View in PubMed
  2. Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem AI, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma. JAMA Surg. 2016 Apr 1; 151(4):365-73. View in PubMed
  3. Margonis GA, Amini N, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Moses LE, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM. Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival. World J Surg. 2016 Mar; 40(3):706-14. View in PubMed
  4. Suh I, Yingling C, Randolph GW, Duh QY. A Novel Method of Neuromonitoring in Thyroidectomy and Parathyroidectomy Using Transcutaneous Intraoperative Vagal Stimulation. JAMA Surg. 2016 Mar 1; 151(3):290-2. View in PubMed
  5. Postlewait LM, Ethun CG, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Staley CA, Poultsides GA, Maithel SK. Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group. J Am Coll Surg. 2016 Apr; 222(4):480-90. View in PubMed
  6. Kluijfhout WP, Pasternak JD, Kwon JS, Lim J, Shen WT, Gosnell JE, Khanafshar E, Duh QY, Suh I. Microscopic Positive Tumor Margin Does Not Increase the Risk of Recurrence in Patients with T1-T2 Well-Differentiated Thyroid Cancer. Ann Surg Oncol. 2016 May; 23(5):1446-51. View in PubMed
  7. Pasternak JD, Epelboym I, Seiser N, Wingo M, Herman M, Cowan V, Gosnell JE, Shen WT, Kerlan RK, Lee JA, Duh QY, Suh I. Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein. Surgery. 2016 Jan; 159(1):267-74. View in PubMed
  8. Madani A, Watanabe Y, Vassiliou M, Feldman LS, Duh QY, Singer MC, Ruan DT, Tabah R, Mitmaker E. Defining competencies for safe thyroidectomy: An international Delphi consensus. Surgery. 2016 Jan; 159(1):86-101. View in PubMed
  9. Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McCaffrey JC, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Hoffmann KG, Hughes M. Anaplastic Thyroid Carcinoma, Version 2.2015. J Natl Compr Canc Netw. 2015 Sep; 13(9):1140-50. View in PubMed
  10. Valero-Elizondo J, Kim Y, Prescott JD, Margonis GA, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM. Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma. J Gastrointest Surg. 2015 Dec; 19(12):2154-61. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Quan-Yang Duh, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X